Mini Review
Rapid Review on Inflammatory Bowel Disease: Current Management and Future Research
Sepideh Khazeni, Freelance Research Scientist, Australia.
Received Date: October 12, 2021; Published Date: November 02, 2021
Introduction
Inflammatory bowel disease (IBD) is a chronic and progressive inflammatory condition involving the gastrointestinal (GI) tract with an increased risk for colon cancer. Two main IBD are affecting the GI tract: Crohn’s disease (CD) that the inflammatory conditions that can affect the entire GI tract, and ulcerative colitis (UC), in which the inflammatory conditions only affect colonic mucosa [1]. Since 1990, the prevalence of IBD has been stabilizing in western countries, but the incident has been globally accelerating in newly industrialized countries in Africa, Asia, and South America [3]. The exacerbation of IBD forces an excessive economic burden on the healthcare system [4] and impairs patients’ quality of life [4, 5].
-
Sepideh Khazeni, Bahareh Bigdeli. Rapid Review on Inflammatory Bowel Disease: Current Management and Future Research. Acad J Gastroenterol & Hepatol. 3(1): 2021. AJGH.MS.ID.000555.